Resumen documental de ASEM
Official National Advisory Committee on Immunization document (2022) on “Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14]”. NACI recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age: Methods, clinical trial data, efficacy, immunogenicity, administration, safety, adverse events and more.
Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.
Documento oficial